China Dominating Global Tetraspecific Antibody Clinical Trials Development Landscape Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- China has emerged as a dominant force in the field of tetraspecific antibodies, leading the way in clinical trials and showing promising results in the...

Advent Of Tetraspecific Antibodies In Cancer Therapy Delhi, March 20, 2023 (GLOBE NEWSWIRE) -- In recent years, the pharmaceutical industry has shown a significant interest in developing novel antibody based therapies for the treatment of cancer....